Monthly Archives: March 2019

CROI 2019: Two “game changing regimens” together show promise for preventing TB in people living with HIV

By on .

SEATTLE – A new and shorter drug regimen to prevent tuberculosis illness can safely be given to people with HIV who are on antiretroviral treatment regimens that include dolutegravir, researchers here announced. The finding is good news for people living with HIV for two reasons. The new regimen – consisting of the TB drugs isoniazid […]

CROI 2019: Point-of-care viral load testing improves HIV outcomes, researchers say

By on .

SEATTLE – People living with HIV who undergo HIV viral load testing at the point of health care delivery and receive their results immediately go on to achieve undetectable viral loads at higher rates than people whose  testing is done at laboratories, researchers said here. Results from the Simplifying HIV Treatment and Monitoring – or […]

CROI 2019: The case of the London patient adds validation to one approach towards a cure

By on .

SEATTLE – If you’re counting those in lasting remission from HIV, Dr. John Mellors of the University of Pittsburgh said here today, there’s been a doubling in their numbers. Now there are two. The dry tone of Mellor’s remarks, and the circumspect wording of Dr. Ravindra Gupta, the physician researcher of University College London, who he […]

CROI 2019: Thailand’s strides spanned HIV treatment, prevention and research

By on .

SEATTLE – The first HIV vaccine trials to yield signs of hope happened here. Thailand was also the first Asian country to eliminate mother-to-child transmission of HIV. Now, Thailand has achieved the first part of UNAIDS’ 90-90-90 targets: 98 percent of people infected with HIV know their status. Of that, 70 percent are receiving HIV […]

CROI 2019: Research and a moral obligation add up to a plan to end U.S. HIV incidence

By on .

SEATTLE – Over the last decade, the evidence had continued to mount. From HPTN 052 to Partners 2 that HIV suppressed to undetectable levels is not transmitted, from the first results of antiretroviral drugs used for pre-exposure protection from the virus, to guidelines saying all people with high risks should be offered that option. Theoretically, […]

Guinea study finds drops in facility-based births during West Africa Ebola crisis

By on .

The following is a guest post by Janine Barden O’Fallon, PhD, MEASURE Evaluation Guinea was one of the three most affected countries in the longest and deadliest outbreak of Ebola Virus Disease ever recorded (2014–2015). The disease also had the indirect effects on access to health services and potential mortality from other conditions. My colleagues […]

It’s March 1, so we’re reading why every single day should be “Zero Discrimination Day”

By on .

As  countdowns to ending the global impacts of HIV and TB continue, we’re reading about the effects of laws and attitudes that turn pathways to preventing, diagnosing and treating the diseases into obstacle courses. Today is Zero Discrimination Day. Women and stigma: Conversations of resilience in the war against TB – Stories of sickness and […]